Literature DB >> 31000665

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.

Alberto Papi1, Stefano Petruzzelli2, Stefano Vezzoli2, George Georges3, Leonardo M Fabbri4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31000665     DOI： 10.1183/13993003.00147-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

Review 1.  [Chronic obstructive pulmonary disease: the right treatment for the right patient].

Authors:  Horst Olschewski; Roland Buhl; Georg Christian Funk; Arschang Valipour; Claus F Vogelmeier
Journal:  Internist (Berl)       Date:  2021-04-16       Impact factor: 0.743

Review 2.  Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses.

Authors:  Mario Cazzola; Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera
Journal:  Pulm Ther       Date:  2019-11-02

3.  COPD from an everyday primary care point of view.

Authors:  Antonio L Aguilar-Shea; Julio Bonis
Journal:  J Family Med Prim Care       Date:  2019-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.